StockData

Frazier Life Sciences Acquisition Corp. II (FLSC) company profile

FLSCNasdaqBlank ChecksFiscal year ends December 31
$10.10−0.04 (-0.39%)

Close on Nov 13, 2026Market cap –P/E –Yield –

About Frazier Life Sciences Acquisition Corp. II

Blank Checks, SIC 6770

Frazier Life Sciences Acquisition Corp. II is listed on Nasdaq under the ticker FLSC, in the SEC industry Blank Checks. It is incorporated in E9 and its fiscal year ends on December 31.

Company profile

Company

Legal name
Frazier Life Sciences Acquisition Corp. II
Headquarters
Palo Alto, CA
Address
1001 Page Mill Road, Building 4, Suite B 93404
Phone
(650) 325-5156
Industry
Blank Checks
Incorporated in
E9
Fiscal year ends
December 31

Stock & identifiers

Ticker
FLSC
Exchange
Nasdaq
IPO date
Oct 14, 2026
Filer category
<br>Emerging growth company
SEC CIK
2153598
CUSIP
G37103101
FIGI
BBG025FVLTW9
Share class FIGI
BBG025FVLWC4
EIN
98-1964369

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Albert ChaChief Executive Officer, Director300,000
Francis Sherman AdamsChief Financial Officer–
Alexandra JacksonGeneral Counsel–
Kevin LiChief Business Officer–
Richard Scott StruthersDirector–
Benjamin L. PalleikoDirector–
William FaireyDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Oct 14, 2026
Offer price
$10.00
First trading day
Oct 14, 2026
First-day close
$10.29+2.9%
Lock-up ends (est.)
Apr 12, 2027

“This is an initial public offering of our Class A ordinary shares, par value $0.0001 per share, which we refer to as our public shares, at an initial public offering price of $10.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?